Table 1 Correlation between SPR expression and clinicopathological characteristics.
Variables | SPR expression | Total | χ2 | p value | ||
|---|---|---|---|---|---|---|
High | low | |||||
Age (year) | 5.445 | 0.020 | ||||
≤58 | 18 | 31 | 49 | |||
>58 | 29 | 19 | 48 | |||
T stage | 5.461 | 0.019 | ||||
T1/T2 | 24 | 37 | 61 | |||
T3/T4 | 23 | 13 | 36 | |||
TNM stage | 5.461 | 0.019 | ||||
Ι/II | 24 | 37 | 61 | |||
III/IV | 23 | 13 | 36 | |||
Sex | 4.784 | 0.029 | ||||
Female | 3 | 11 | 14 | |||
Male | 44 | 39 | 83 | |||
Cancer embolus | 0.471 | 0.492 | ||||
No | 28 | 33 | 61 | |||
Yes | 13 | 11 | 24 | |||
Null | 12 | |||||
Cirrhosis | 0.008 | 0.927 | ||||
No | 10 | 11 | 21 | |||
Yes | 33 | 38 | 71 | |||
Null | 5 | |||||
Grade | 0.849 | 0.357 | ||||
I/II | 36 | 35 | 71 | |||
III | 10 | 15 | 25 | |||
Null | 1 | |||||
CD34 | 0.493a | |||||
Negative | 0 | 2 | 2 | |||
Positive | 31 | 31 | 62 | |||
Null | 33 | |||||
CK19 | 0.042 | 0.838 | ||||
Negative | 32 | 35 | 67 | |||
Positive | 15 | 15 | 30 | |||
Recurrence or metastasis | 0.535 | 0.464 | ||||
No | 40 | 45 | 85 | |||
Yes | 7 | 5 | 12 | |||